During the past decade, GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Institut Curie" with 1 trials as a collaborator and "International Drug Development Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk" are "Breast Cancer" (1 trials), "ER-Negative Breast Cancer" (1 trials), "HER2-positive Breast Cancer" (1 trials), "Node-negative Breast Cancer" (1 trials) and "PR-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk" in a lesser frequency.

Most popular intervention types in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin" (1 trials), "Pertuzumab and tratuzumab fixed dose combination" (1 trials), "Trastuzumab emtansine" (1 trials) and "paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".